{"id":"https://openalex.org/W31033320","doi":null,"title":"Minaprine, a new drug with antidepressant properties.","display_name":"Minaprine, a new drug with antidepressant properties.","publication_year":1985,"publication_date":"1985-01-01","ids":{"openalex":"https://openalex.org/W31033320","mag":"31033320","pmid":"https://pubmed.ncbi.nlm.nih.gov/3836113"},"language":"en","primary_location":{"id":"pmid:3836113","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3836113","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs under experimental and clinical research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005450777","display_name":"Kathleen Bizi\u00e8re","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"K Bizi\u00e8re","raw_affiliation_strings":["Sanofi\u2013Aventis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi\u2013Aventis","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062816789","display_name":"P. Worms","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"P Worms","raw_affiliation_strings":["Sanofi\u2013Aventis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi\u2013Aventis","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111552823","display_name":"J.P. Kan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J P Kan","raw_affiliation_strings":["Sanofi\u2013Aventis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi\u2013Aventis","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111562417","display_name":"P. Mandel","orcid":"https://orcid.org/0000-0002-0760-7281","observed_orcids":["https://orcid.org/0000-0002-0760-7281"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Mandel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073550160","display_name":"Silvio K. Garattini","orcid":"https://orcid.org/0000-0003-0647-9297","observed_orcids":["https://orcid.org/0000-0003-0647-9297"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"S Garattini","raw_affiliation_strings":["Istituto Di Ricerche Farmacologiche, Mario Negri"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Di Ricerche Farmacologiche, Mario Negri","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076166593","display_name":"R. Roncucci","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Roncucci","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.3637,"has_fulltext":false,"cited_by_count":47,"citation_normalized_percentile":{"value":0.86720816,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"11","issue":"12","first_page":"831","last_page":"40"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9092000126838684,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9092000126838684,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.08749999850988388,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/minaprine","display_name":"minaprine","score":1.0},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.7580000162124634},{"id":"https://openalex.org/keywords/psychotropic-drugs","display_name":"psychotropic drugs","score":0.7570000290870667},{"id":"https://openalex.org/keywords/serotonin","display_name":"serotonin","score":0.5299999713897705},{"id":"https://openalex.org/keywords/dopamine","display_name":"dopamine","score":0.9649999737739563},{"id":"https://openalex.org/keywords/dopaminergic-neurotransmission","display_name":"dopamine signaling","score":0.7089999914169312},{"id":"https://openalex.org/keywords/serotonin-receptors","display_name":"serotonin receptors","score":0.5180000066757202},{"id":"https://openalex.org/keywords/5-ht1-receptors","display_name":"5-HT1 receptors","score":0.6549999713897705},{"id":"https://openalex.org/keywords/5-ht2-receptor","display_name":"5-HT2 receptor","score":0.9980000257492065},{"id":"https://openalex.org/keywords/monoamine-oxidase-inhibition","display_name":"monoamine oxidase inhibition","score":0.7409999966621399},{"id":"https://openalex.org/keywords/striatum","display_name":"striatum","score":0.6129999756813049},{"id":"https://openalex.org/keywords/stereotyped-behavior","display_name":"stereotypy","score":0.5740000009536743},{"id":"https://openalex.org/keywords/catalepsy","display_name":"catalepsy","score":0.7570000290870667},{"id":"https://openalex.org/keywords/reserpine","display_name":"reserpine","score":0.5249999761581421},{"id":"https://openalex.org/keywords/behavioural-despair","display_name":"behavioural despair","score":0.5400000214576721},{"id":"https://openalex.org/keywords/5-hydroxyindoleacetic-acid","display_name":"5-hydroxyindoleacetic acid","score":0.6949999928474426},{"id":"https://openalex.org/keywords/anticholinergic-effects","display_name":"anticholinergic effects","score":0.6389999985694885}],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5818658471107483},{"id":"https://openalex.org/C2780062018","wikidata":"https://www.wikidata.org/wiki/Q1319792","display_name":"Striatum","level":3,"score":0.5310091376304626},{"id":"https://openalex.org/C2781073084","wikidata":"https://www.wikidata.org/wiki/Q3077150","display_name":"Spiperone","level":4,"score":0.4902408719062805},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.4861266613006592},{"id":"https://openalex.org/C2777842393","wikidata":"https://www.wikidata.org/wiki/Q407841","display_name":"Reserpine","level":2,"score":0.474263072013855},{"id":"https://openalex.org/C2777525119","wikidata":"https://www.wikidata.org/wiki/Q269111","display_name":"Apomorphine","level":4,"score":0.4583870768547058},{"id":"https://openalex.org/C2777676773","wikidata":"https://www.wikidata.org/wiki/Q412226","display_name":"Yohimbine","level":4,"score":0.4551200866699219},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.4379500448703766},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.3822326362133026},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3470671474933624},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.34184038639068604},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.33021044731140137},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3243679106235504},{"id":"https://openalex.org/C120069818","wikidata":"https://www.wikidata.org/wiki/Q415496","display_name":"Dopamine receptor","level":3,"score":0.30998551845550537},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.26202261447906494},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.0999315083026886},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.09476715326309204}],"mesh":[{"descriptor_ui":"D000109","descriptor_name":"Acetylcholine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001679","descriptor_name":"Biogenic Amines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002375","descriptor_name":"Catalepsy","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011954","descriptor_name":"Receptors, Dopamine","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013239","descriptor_name":"Stereotyped Behavior","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:3836113","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3836113","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs under experimental and clinical research","raw_type":"Journal Article"},{"id":"mag:31033320","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3836113","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W191075690","https://openalex.org/W2411728943","https://openalex.org/W2485182299","https://openalex.org/W2503620947","https://openalex.org/W2409231558","https://openalex.org/W2009801419","https://openalex.org/W2064478379","https://openalex.org/W2403046095","https://openalex.org/W1967809697","https://openalex.org/W1977210360"],"abstract_inverted_index":{"Minaprine":[0,81,225],"is":[1,283,293],"a":[2,118,196,267],"new":[3],"psychotropic":[4],"drug":[5,92,212,273],"which":[6,144,274,282],"has":[7],"recently":[8],"proved":[9],"to":[10,195,242,265],"be":[11,266],"effective":[12],"in":[13,33,44,55,79,99,115,139,153,180,198,208,249,259,302,315],"the":[14,37,45,51,91,122,199,209,211,296,309],"treatment":[15],"of":[16,27,39,53,121,201,285,300,311],"various":[17,181],"depressive":[18],"states.":[19],"In":[20,107,170,206],"rodents,":[21],"minaprine":[22,35,67,109,133,145,155,172,240,263,301],"exhibits":[23],"an":[24],"atypical":[25],"spectrum":[26],"antidepressant":[28,272],"and":[29,49,73,96,163,184,186,203,215,217,234,252,269,278,287,305,307],"dopaminomimetic":[30,131],"activities.":[31],"Thus":[32,87,262],"mice":[34,116],"antagonizes":[36,58,93],"effects":[38,52,78,148],"reserpine,":[40],"decreases":[41,177,213],"immobility":[42],"time":[43],"behavioural":[46],"despair":[47],"test":[48],"potentiates":[50],"5-HTP;":[54],"rats":[56],"it":[57],"muricidal":[59],"behaviour":[60],"(blocked":[61],"by":[62,105,143,295,308],"PCPA":[63],"or":[64,161,246],"raphectomy).":[65],"However,":[66],"does":[68,74,134,156,164,253],"not":[69,75,135,157,165,254],"affect":[70,158,243],"yohimbine":[71],"lethality":[72],"induce":[76],"anticholinergic":[77,288,313],"mice.":[80],"also":[82,226],"activates":[83,275],"central":[84],"dopaminergic":[85],"transmission.":[86],"at":[88],"low":[89],"doses":[90,251],"neuroleptic-induced":[94],"catalepsy":[95],"induces":[97,112,126],"stereotypies":[98,102],"rats.":[100,140],"These":[101],"are":[103,149],"blocked":[104],"neuroleptics.":[106],"addition,":[108,207],"(like":[110],"apomorphine)":[111],"contralateral":[113],"turning":[114],"with":[117,167],"unilateral":[119],"lesion":[120],"striatum,":[123],"whereas":[124],"d-amphetamine":[125],"ipsilateral":[127],"rotations.":[128],"Unlike":[129],"classical":[130],"drugs,":[132],"stimulate":[136],"locomotor":[137],"activity":[138],"The":[141],"mechanisms":[142],"exerts":[146],"its":[147],"still":[150],"unclear,":[151],"since":[152],"vitro":[154],"monoamine":[159,168],"uptake":[160],"release":[162],"interact":[166],"receptors.":[169,205],"vivo,":[171],"(acute":[173],"doses)":[174],"increases":[175,218,235],"5-HT,":[176],"5-HIAA":[178],"levels":[179,248],"brain":[182,244],"areas":[183],"weakly":[185,227],"reversibly":[187],"inhibits":[188],"type":[189],"A":[190],"MAO;":[191],"subacute":[192,260],"treatments":[193],"lead":[194],"decrease":[197],"number":[200],"5-HT1":[202],"5-HT2":[204],"striatum":[210],"HVA":[214],"DOPAC,":[216],"3-MT":[219],"levels,":[220],"without":[221],"affecting":[222],"DA":[223],"levels.":[224,238],"displaces":[228],"(3H)-spiperone":[229],"from":[230],"striatal":[231,236],"D2":[232],"receptors":[233],"ACh":[237],"Finally,":[239],"fails":[241],"NA":[245],"MHPG":[247],"acute":[250],"modify":[255],"beta":[256],"receptor":[257],"density":[258],"treatment.":[261],"appears":[264],"chemically":[268],"pharmacologically":[270],"original":[271],"both":[276],"5-HT-":[277],"DA-mediated":[279],"transmission":[280],"but":[281],"devoid":[284],"NAergic":[286],"effects.":[289],"This":[290],"latter":[291],"statement":[292],"confirmed":[294],"good":[297],"cardiovascular":[298],"tolerance":[299],"dog,":[303],"monkey":[304],"humans,":[306],"lack":[310],"\"tricyclic-like\"":[312],"side-effects":[314],"man.":[316]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}